101 related articles for article (PubMed ID: 8058235)
1. Alprazolam in the treatment of two subsamples of patients with late luteal phase dysphoric disorder: a double-blind, placebo-controlled crossover study.
Berger CP; Presser B
Obstet Gynecol; 1994 Sep; 84(3):379-85. PubMed ID: 8058235
[TBL] [Abstract][Full Text] [Related]
2. Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial.
Smith S; Rinehart JS; Ruddock VE; Schiff I
Obstet Gynecol; 1987 Jul; 70(1):37-43. PubMed ID: 3299178
[TBL] [Abstract][Full Text] [Related]
3. Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase.
Yonkers KA; Pearlstein T; Fayyad R; Gillespie JA
J Affect Disord; 2005 Apr; 85(3):317-21. PubMed ID: 15780701
[TBL] [Abstract][Full Text] [Related]
4. Fluoxetine in the treatment of late luteal phase dysphoric disorder.
Stone AB; Pearlstein TB; Brown WA
J Clin Psychiatry; 1991 Jul; 52(7):290-3. PubMed ID: 2071558
[TBL] [Abstract][Full Text] [Related]
5. Long-term fluoxetine treatment of late luteal phase dysphoric disorder.
Pearlstein TB; Stone AB
J Clin Psychiatry; 1994 Aug; 55(8):332-5. PubMed ID: 8071300
[TBL] [Abstract][Full Text] [Related]
6. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.
Steiner M; Steinberg S; Stewart D; Carter D; Berger C; Reid R; Grover D; Streiner D
N Engl J Med; 1995 Jun; 332(23):1529-34. PubMed ID: 7739706
[TBL] [Abstract][Full Text] [Related]
7. Symptoms of depression in late luteal phase dysphoric disorder: a variant of mood disorder?
De Ronchi D; Ujkaj M; Boaron F; Muro A; Piselli M; Quartesan R
J Affect Disord; 2005 Jun; 86(2-3):169-74. PubMed ID: 15935236
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial.
Brown CS; Ling FW; Andersen RN; Farmer RG; Arheart KL
Obstet Gynecol; 1994 Nov; 84(5):779-86. PubMed ID: 7936512
[TBL] [Abstract][Full Text] [Related]
9. Tryptophan in the treatment of late luteal phase dysphoric disorder: a pilot study.
Steinberg S; Annable L; Young SN; Bélanger MC
J Psychiatry Neurosci; 1994 Mar; 19(2):114-9. PubMed ID: 8204563
[TBL] [Abstract][Full Text] [Related]
10. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
Lydiard RB; Ballenger JC; Rickels K
J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
[TBL] [Abstract][Full Text] [Related]
11. Mood and performance changes in women with premenstrual dysphoric disorder: acute effects of alprazolam.
Evans SM; Haney M; Levin FR; Foltin RW; Fischman MW
Neuropsychopharmacology; 1998 Dec; 19(6):499-516. PubMed ID: 9803426
[TBL] [Abstract][Full Text] [Related]
12. A double-blind comparative study of alprazolam and dothiepin hydrochloride in the treatment of anxiety associated with depression.
Cropper M; Garner A; McEwan GD; Munt DF; Rushbrook LA; Stevens V; Baker AC
Pharmatherapeutica; 1987; 5(2):76-82. PubMed ID: 3310018
[TBL] [Abstract][Full Text] [Related]
13. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome.
Freeman EW; Rickels K; Sondheimer SJ; Polansky M
JAMA; 1995 Jul; 274(1):51-7. PubMed ID: 7791258
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
15. Medical management of premenstrual dysphoric disorder.
Yonkers KA
J Gend Specif Med; 1999; 2(3):55-60. PubMed ID: 11252853
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study.
Freeman EW; Sondheimer SJ; Rickels K
Psychopharmacol Bull; 1997; 33(2):303-9. PubMed ID: 9230648
[TBL] [Abstract][Full Text] [Related]
17. Altered sensitivity to alcohol in the late luteal phase among patients with premenstrual dysphoric disorder.
Nyberg S; Wahlström G; Bäckström T; Sundström Poromaa I
Psychoneuroendocrinology; 2004 Jul; 29(6):767-77. PubMed ID: 15110926
[TBL] [Abstract][Full Text] [Related]
18. Persistence of premenstrual syndrome during low-dose administration of the progesterone antagonist RU 486.
Chan AF; Mortola JF; Wood SH; Yen SS
Obstet Gynecol; 1994 Dec; 84(6):1001-5. PubMed ID: 7970453
[TBL] [Abstract][Full Text] [Related]
19. Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial.
Miner C; Brown E; McCray S; Gonzales J; Wohlreich M
Clin Ther; 2002 Mar; 24(3):417-33. PubMed ID: 11952025
[TBL] [Abstract][Full Text] [Related]
20. Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial.
Schmidt PJ; Grover GN; Rubinow DR
Arch Gen Psychiatry; 1993 Jun; 50(6):467-73. PubMed ID: 8498881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
